Similar articles for PMID: 12548176

Year	Number of Results
1992	1
1994	4
1995	7
1996	7
1997	13
1998	10
1999	6
2000	7
2001	20
2002	3
2003	5
2004	4
2008	3
2009	1
2024	0

1

Difference between familial and sporadic medullary thyroid carcinomas.

Mears L, Diaz-Cano SJ. Mears L, et al. Am J Surg Pathol. 2003 Feb;27(2):266-7. doi: 10.1097/00000478-200302000-00018. Am J Surg Pathol. 2003. PMID: 12548176 No abstract available.

2

Editorial review of "Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 RET germline mutations".

Wilhelm S, Prinz RA. Wilhelm S, et al. Surgery. 2004 Apr;135(4):447-8. doi: 10.1016/s0039-6060(03)00349-0. Surgery. 2004. PMID: 15041969 No abstract available.

3

[C cell hyperplasia and medullary microcarcinomas of the thyroid].

Guyetant S, Saint-Andre JP. Guyetant S, et al. Ann Pathol. 2000;20 Suppl:S39-44. Ann Pathol. 2000. PMID: 11261296 Review. French. No abstract available.

4

Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.

Niccoli-Sire P, Murat A, Rohmer V, Franc S, Chabrier G, Baldet L, Maes B, Savagner F, Giraud S, Bezieau S, Kottler ML, Morange S, Conte-Devolx B; French Calcitonin Tumors Group (GETC). Niccoli-Sire P, et al. J Clin Endocrinol Metab. 2001 Aug;86(8):3746-53. doi: 10.1210/jcem.86.8.7767. J Clin Endocrinol Metab. 2001. PMID: 11502806

5

Surgical treatment of medullary carcinoma of the thyroid.

Favia G, Lumachi F. Favia G, et al. Tumori. 2001 Jul-Aug;87(4):S49-51. Tumori. 2001. PMID: 11693822 No abstract available.

6

RET activation in medullary carcinomas.

Pierotti MA, Arighi E, Degl'innocenti D, Borrello MG. Pierotti MA, et al. Cancer Treat Res. 2004;122:389-415. Cancer Treat Res. 2004. PMID: 16209058 Review. No abstract available.

7

A novel germline point mutation, c.2304 G-->T, in codon 768 of the RET proto-oncogene in a patient with medullary thyroid carcinoma.

Antiñolo G, Marcos I, Fernández RM, Romero M, Borrego S. Antiñolo G, et al. Am J Med Genet. 2002 Jun 1;110(1):85-7. doi: 10.1002/ajmg.10399. Am J Med Genet. 2002. PMID: 12116277 No abstract available.

8

Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RET.

Kasprzak L, Nolet S, Gaboury L, Pavia C, Villabona C, Rivera-Fillat F, Oriola J, Foulkes WD. Kasprzak L, et al. J Med Genet. 2001 Nov;38(11):784-7. doi: 10.1136/jmg.38.11.784. J Med Genet. 2001. PMID: 11732489 Free PMC article. No abstract available.

9

Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.

Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F, Martino E, Romeo G, Pacini F. Romei C, et al. J Clin Endocrinol Metab. 1996 Apr;81(4):1619-22. doi: 10.1210/jcem.81.4.8636377. J Clin Endocrinol Metab. 1996. PMID: 8636377

10

Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.

Matias-Guiu X, Lagarda E, Calaf M, Azpiroz A, De Leiva A, Prat J, Baiget M. Matias-Guiu X, et al. Hum Mutat. 1997;9(5):476. doi: 10.1002/(SICI)1098-1004(1997)9:5<476::AID-HUMU20>3.0.CO;2-Z. Hum Mutat. 1997. PMID: 9143934 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

90 results

Results by year